<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00700700</url>
  </required_header>
  <id_info>
    <org_study_id>DMED-1082-07</org_study_id>
    <nct_id>NCT00700700</nct_id>
  </id_info>
  <brief_title>Cardiac Resynchronization Therapy, Dyspnea and Exercise Tolerance in Patients With Congestive Heart Failure (CHF)</brief_title>
  <official_title>Effects of Cardiac Resynchronization Therapy on Dyspnea and Exercise Tolerance in Patients With Congestive Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen's University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Queen's University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A new therapy for patients with advanced heart failure (HF) involves the implantation of a
      specialized pacemaker device (Cardiac Resynchronization Therapy, CRT) that attempts to
      restore the synchronized contraction of the ventricular chambers of the heart. In some
      people, CRT improves exertional breathlessness and allows them to exercise for longer
      periods. However, to date, the mechanisms by which CRT improves symptoms and exercise
      tolerance is unknown. This study will use in-depth cardiopulmonary exercise testing and
      pulmonary function testing to explore these mechanisms in greater detail.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Stopped due to an inability to recruit eligible subjects.
  </why_stopped>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exercise endurance time</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Congestive Heart Failure</condition>
  <arm_group>
    <arm_group_label>CRT-ON/CRT-OFF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group initially randomized to CRT-ON, then cross-over to CRT-OFF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CRT-OFF/CRT-ON</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group initially randomized to CRT-OFF, then cross-over to CRT-ON</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active Cardiac Resynchronization Therapy (CRT)</intervention_name>
    <description>Initiation of active biventricular pacing/cardiac resynchronization therapy
Devices by Medtronic:
Insync Sentry 7298 &amp; 7299
Concerto C174 ASK (Most frequently implanted)
Insync III 8042 (PM)
Devices by Guidant/Boston Scientific:
Contak Renewal 4 H190 &amp; H199
Contak Renewal 3 H127
Devices by ELA/Sorin:
1. Ovatio CRT 6750</description>
    <arm_group_label>CRT-ON/CRT-OFF</arm_group_label>
    <arm_group_label>CRT-OFF/CRT-ON</arm_group_label>
    <other_name>Received one of the above devices used in 2007-2008 at Kingston General Hospital.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinically stable

          -  being considered for implantation of biventricular pacemaker for CRT

          -  LVEF &lt;35%

          -  QRS duration &gt;120 msec

          -  NYHA III-IV functional class

          -  optimized pharmacologic management of CHF

          -  no recent (&lt;1 month) episodes of decompensated CHF

        Exclusion Criteria:

          -  inability to perform cycle ergometry or comply with testing

          -  uncontrolled ischemic heart disease

          -  coronary revascularization within 3 months of study entry

          -  concurrent primary lung disease

          -  current use of ambulatory oxygen

          -  rhythm other than sinus

          -  dependency on pacemaker therapy as a consequence of bradyarrhythmias

          -  severe valvulopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris M. Parker, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen's University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kingston General Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 3N6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2008</study_first_submitted>
  <study_first_submitted_qc>June 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2008</study_first_posted>
  <last_update_submitted>July 4, 2011</last_update_submitted>
  <last_update_submitted_qc>July 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Chris M. Parker, Assistant Professor</name_title>
    <organization>Queen's University</organization>
  </responsible_party>
  <keyword>Congestive Heart Failure</keyword>
  <keyword>Cardiac Resynchronization Therapy</keyword>
  <keyword>Dyspnea</keyword>
  <keyword>Exercise Tolerance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

